Literature DB >> 32140727

Inflammation Triggered by Saturated Fat Ingestion Is Linked to Insulin Resistance and Hyperandrogenism in Polycystic Ovary Syndrome.

Frank González1, Robert V Considine2, Ola A Abdelhadi3, Anthony J Acton2.   

Abstract

CONTEXT: Inflammation and insulin resistance are often present in polycystic ovary syndrome (PCOS).
OBJECTIVE: We determined the effect of saturated fat ingestion on mononuclear cell (MNC) nuclear factor-κB (NFκB) activation; NFκB, inhibitory-κBα (IκBα), and tumor necrosis factor-α (TNFα) gene expression; and circulating C-reactive protein (CRP) in women with PCOS.
DESIGN: Cross-sectional study.
SETTING: Academic medical center. PATIENTS: Twenty reproductive-age women with PCOS (10 lean, 10 with obesity) and 20 ovulatory controls (10 lean, 10 with obesity). MAIN OUTCOME MEASURES: Activated NFκB, NFκB heterodimer subunits, IκBα and TNFα messenger ribonucleic acid content and NFκB p65 and IκBα protein content were quantified in mononuclear cells (MNC), and CRP was measured in plasma from blood drawn fasting and 2, 3, and 5 h after saturated fat ingestion. Insulin sensitivity was derived from oral glucose tolerance testing (ISOGTT). Androgen secretion was assessed from blood drawn fasting and 24, 48, and 72 h after human chorionic gonadotropin (HCG) administration.
RESULTS: In response to saturated fat ingestion, women with PCOS regardless of weight class exhibited lipid-induced increases in activated NFκB, NFκB, and TNFα gene expression and plasma CRP and decreases in IκBα protein compared with lean control subjects. Both PCOS groups exhibited lower ISOGTT and greater HCG-stimulated androgen secretion compared with control subjects. Lipid-stimulated NFκB activation was negatively correlated with ISOGTT, and positively correlated with HCG-stimulated androgen secretion.
CONCLUSION: In PCOS, increases in NFκB activation and circulating CRP and decreases in IκBα protein following saturated fat ingestion are independent of obesity. Circulating MNC and excess adipose tissue are separate and distinct contributors to inflammation in this disorder. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  hyperandrogenism; insulin resistance; polycystic ovary syndrome; saturated fat

Mesh:

Substances:

Year:  2020        PMID: 32140727      PMCID: PMC7150616          DOI: 10.1210/clinem/dgaa108

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  50 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Role of oxidants in NF-kappa B activation and TNF-alpha gene transcription induced by hypoxia and endotoxin.

Authors:  N S Chandel; W C Trzyna; D S McClintock; P T Schumacker
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

3.  Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance.

Authors:  Enrico Carmina; Salvo Bucchieri; Antonella Esposito; Antonio Del Puente; Pasquale Mansueto; Francesco Orio; Gaetana Di Fede; Giovambattista Rini
Journal:  J Clin Endocrinol Metab       Date:  2007-04-03       Impact factor: 5.958

4.  The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation.

Authors:  Alexander Hoffmann; Andre Levchenko; Martin L Scott; David Baltimore
Journal:  Science       Date:  2002-11-08       Impact factor: 47.728

5.  HMG-CoA reductase inhibitors reduce I kappa B kinase activity induced by oxidative stress in monocytes and vascular smooth muscle cells.

Authors:  Monica Ortego; Almundena Gómez-Hernández; Cristina Vidal; Eva Sánchez-Galán; Luis M Blanco-Colio; Jose L Martín-Ventura; Jose Tuñón; Cristina Diaz; Gonzalo Hernández; Jesus Egido
Journal:  J Cardiovasc Pharmacol       Date:  2005-05       Impact factor: 3.105

6.  Effects of Resveratrol on Polycystic Ovary Syndrome: A Double-blind, Randomized, Placebo-controlled Trial.

Authors:  Beata Banaszewska; Joanna Wrotyńska-Barczyńska; Robert Z Spaczynski; Leszek Pawelczyk; Antoni J Duleba
Journal:  J Clin Endocrinol Metab       Date:  2016-10-18       Impact factor: 5.958

7.  SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice.

Authors:  B Emanuelli; P Peraldi; C Filloux; C Chavey; K Freidinger; D J Hilton; G S Hotamisligil; E Van Obberghen
Journal:  J Biol Chem       Date:  2001-10-16       Impact factor: 5.157

8.  Inflammation in response to glucose ingestion is independent of excess abdominal adiposity in normal-weight women with polycystic ovary syndrome.

Authors:  Frank González; Chang Ling Sia; Marguerite K Shepard; Neal S Rote; Judi Minium
Journal:  J Clin Endocrinol Metab       Date:  2012-08-17       Impact factor: 5.958

9.  Obesity is associated with macrophage accumulation in adipose tissue.

Authors:  Stuart P Weisberg; Daniel McCann; Manisha Desai; Michael Rosenbaum; Rudolph L Leibel; Anthony W Ferrante
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

10.  A central role for hepatocyte growth factor in adipose tissue angiogenesis.

Authors:  Lauren N Bell; Liying Cai; Brian H Johnstone; Dmitry O Traktuev; Keith L March; Robert V Considine
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-12-11       Impact factor: 4.310

View more
  12 in total

1.  Lipid-induced mononuclear cell cytokine secretion in the development of metabolic aberration and androgen excess in polycystic ovary syndrome.

Authors:  F González; R V Considine; O A Abdelhadi; A J Acton
Journal:  Hum Reprod       Date:  2020-05-01       Impact factor: 6.918

2.  Current concepts of polycystic ovary syndrome pathogenesis.

Authors:  Robert L Rosenfield
Journal:  Curr Opin Pediatr       Date:  2020-10       Impact factor: 2.856

3.  Saturated fat ingestion stimulates proatherogenic inflammation in polycystic ovary syndrome.

Authors:  Frank González; Robert V Considine; Ola A Abdelhadi; Jiaping Xue; Anthony J Acton
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-10-11       Impact factor: 4.310

4.  Proteomic alteration of endometrial tissues during secretion in polycystic ovary syndrome may affect endometrial receptivity.

Authors:  Jun Li; Xiaohua Jiang; Caihua Li; Huihui Che; Lin Ling; Zhaolian Wei
Journal:  Clin Proteomics       Date:  2022-05-28       Impact factor: 5.000

Review 5.  The Role of Nutrition on Meta-inflammation: Insights and Potential Targets in Communicable and Chronic Disease Management.

Authors:  Omar Ramos-Lopez; Diego Martinez-Urbistondo; Juan A Vargas-Nuñez; J Alfredo Martinez
Journal:  Curr Obes Rep       Date:  2022-10-18

6.  The effect of TCF7L2 polymorphisms on inflammatory markers after 16 weeks of legume-based dietary approach to stop hypertension (DASH) diet versus a standard DASH diet: a randomised controlled trial.

Authors:  Somayeh Hosseinpour-Niazi; Parvin Mirmiran; Farzad Hadaegh; Maryam S Daneshpour; Mehdi Hedayati; Fereidoun Azizi
Journal:  Nutr Metab (Lond)       Date:  2022-05-18       Impact factor: 4.654

Review 7.  The Kynurenine Pathway and Polycystic Ovary Syndrome: Inflammation as a Common Denominator.

Authors:  Filip Jovanovic; Aboorva Sudhakar; Nebojsa Nick Knezevic
Journal:  Int J Tryptophan Res       Date:  2022-05-21

Review 8.  The role of miRNAs in polycystic ovary syndrome with insulin resistance.

Authors:  Yingliu Luo; Chenchen Cui; Xiao Han; Qian Wang; Cuilian Zhang
Journal:  J Assist Reprod Genet       Date:  2021-01-06       Impact factor: 3.412

9.  The Role of Chronic Inflammation in Polycystic Ovarian Syndrome-A Systematic Review and Meta-Analysis.

Authors:  Shaimaa Aboeldalyl; Cathryn James; Emaduldin Seyam; Emad Moussa Ibrahim; Hossam El-Din Shawki; Saad Amer
Journal:  Int J Mol Sci       Date:  2021-03-08       Impact factor: 5.923

10.  Association of Prx4, Total Oxidant Status, and Inflammatory Factors with Insulin Resistance in Polycystic Ovary Syndrome.

Authors:  Sahar Mazloomi; Nasrin Sheikh; Marzieh Sanoee Farimani; Shamim Pilehvari
Journal:  Int J Endocrinol       Date:  2021-06-22       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.